Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines.

Crow LD, Jambusaria-Pahlajani A, Chung CL, Baran DA, Lowenstein SE, Abdelmalek M, Ahmed RL, Anadkat MJ, Arcasoy SM, Berg D, Bibee KP, Billingsley E, Black WH, Blalock TW, Bleicher M, Brennan DC, Brodland DG, Brown MR, Carroll BT, Carucci JA, Chang TW, Chaux G, Cusack CA, Dilling DF, Doyle A, Emtiazjoo AM, Ferguson NH, Fosko SW, Fox MC, Goral S, Gray AL, Griffin JR, Hachem RR, Hall SA, Hanlon AM, Hayes D Jr, Hickey GW, Holtz J, Hopkins RS, Hu J, Huang CC, Brian Jiang SI, Kapnadak SG, Kraus ES, Lease ED, Leca N, Lee JC, Leitenberger JJ, Lim MA, Longo MI, Malik SM, Mallea JM, Menter A, Myers SA, Neuburg M, Nijhawan RI, Norman DJ, Otley CC, Paek SY, Parulekar AD, Patel MJ, Patel VA, Patton TJ, Pugliano-Mauro M, Ranganna K, Ravichandran AK, Redenius R, Roll GR, Samie FH, Shin T, Singer JP, Singh P, Soon SL, Soriano T, Squires R, Stasko T, Stein JA, Taler SJ, Terrault NA, Thomas CP, Tokman S, Tomic R, Twigg AR, Wigger MA, Zeitouni NC, Arron ST.

Transpl Int. 2019 Sep 10. doi: 10.1111/tri.13520. [Epub ahead of print]

PMID:
31502728
2.

Safety and Efficacy of Universal Postoperative Decolonization for Kidney Transplant Recipients.

Lee DH, Malat G, Boyle SM, Talluri S, Bias TE, Harhay MN, Ranganna K, Doyle A.

Exp Clin Transplant. 2019 Jul 2. doi: 10.6002/ect.2018.0341. [Epub ahead of print]

3.

Cellular Effects of Butyrate on Vascular Smooth Muscle Cells are Mediated through Disparate Actions on Dual Targets, Histone Deacetylase (HDAC) Activity and PI3K/Akt Signaling Network.

Mathew OP, Ranganna K, Mathew J, Zhu M, Yousefipour Z, Selvam C, Milton SG.

Int J Mol Sci. 2019 Jun 14;20(12). pii: E2902. doi: 10.3390/ijms20122902.

4.

Association Between Weight Loss Before Deceased Donor Kidney Transplantation and Posttransplantation Outcomes.

Harhay MN, Ranganna K, Boyle SM, Brown AM, Bajakian T, Levin Mizrahi LB, Xiao G, Guy S, Malat G, Segev DL, Reich D, McAdams-DeMarco M.

Am J Kidney Dis. 2019 Sep;74(3):361-372. doi: 10.1053/j.ajkd.2019.03.418. Epub 2019 May 21.

PMID:
31126666
5.

Association of the kidney allocation system with dialysis exposure before deceased donor kidney transplantation by preemptive wait-listing status.

Harhay MN, Harhay MO, Ranganna K, Boyle SM, Levin Mizrahi L, Guy S, Malat GE, Xiao G, Reich DJ, Patzer RE.

Clin Transplant. 2018 Oct;32(10):e13386. doi: 10.1111/ctr.13386. Epub 2018 Sep 15.

6.

Meta-Analysis Comparing Outcomes and Need for Renal Replacement Therapy of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement.

Siddiqui WJ, Alvarez C, Aslam M, Bakar A, Khan MH, Aslam A, Hanif MO, Hasni SF, Ranganna K, Eisen H, Aggarwal S.

Am J Cardiol. 2018 Aug 1;122(3):468-476. doi: 10.1016/j.amjcard.2018.04.030. Epub 2018 May 3. Review.

PMID:
29958709
7.

Association between Medicaid Expansion under the Affordable Care Act and Preemptive Listings for Kidney Transplantation.

Harhay MN, McKenna RM, Boyle SM, Ranganna K, Mizrahi LL, Guy S, Malat GE, Xiao G, Reich DJ, Harhay MO.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1069-1078. doi: 10.2215/CJN.00100118. Epub 2018 Jun 21.

8.

Kidney Transplantation in HIV-Positive Patients: A Single-Center, 16-Year Experience.

Malat GE, Boyle SM, Jindal RM, Guy S, Xiao G, Harhay MN, Lee DH, Ranganna KM, Anil Kumar MS, Doyle AM.

Am J Kidney Dis. 2019 Jan;73(1):112-118. doi: 10.1053/j.ajkd.2018.02.352. Epub 2018 Apr 25.

PMID:
29705074
9.

Regulation of hypoxia inducible factor/prolyl hydroxylase binding domain proteins 1 by PPARĪ± and high salt diet.

Ozurumba E, Mathew O, Ranganna K, Choi M, Oyekan A.

J Basic Clin Physiol Pharmacol. 2018 Mar 28;29(2):165-173. doi: 10.1515/jbcpp-2017-0074.

PMID:
29500923
10.

Exosomes Mediate the Beneficial Effects of Exercise.

Li Y, Han C, Wang J, Zhou J, Liang C, Ranganna K, Song YH.

Adv Exp Med Biol. 2017;1000:333-353. doi: 10.1007/978-981-10-4304-8_18. Review.

PMID:
29098629
11.

Barriers to listing for HIV-infected patients being evaluated for kidney transplantation.

Lee DH, Boyle SM, Malat GE, Kern C, Milrod C, DeBellis S, Harhay MN, Ranganna K, Guy S, Talluri S, Bias T, Doyle A.

Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12777. Epub 2017 Oct 5.

12.

Association of tenofovir disoproxil fumarate with primary allograft survival in HIV-positive kidney transplant recipients.

Boyle SM, Malat G, Harhay MN, Lee DH, Pang L, Talluri S, Sharma A, Bias TE, Ranganna K, Doyle AM.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12727. Epub 2017 Jul 28.

PMID:
28520146
13.

Therapeutic potential of chemically modified siRNA: Recent trends.

Selvam C, Mutisya D, Prakash S, Ranganna K, Thilagavathi R.

Chem Biol Drug Des. 2017 Nov;90(5):665-678. doi: 10.1111/cbdd.12993. Epub 2017 May 16. Review.

14.

Contribution of PPARĪ³ in modulation of acrolein-induced inflammatory signaling in gp91phox knock-out mice.

Yousefipour Z, Chug N, Marek K, Nesbary A, Mathew J, Ranganna K, Newaz MA.

Biochem Cell Biol. 2017 Aug;95(4):482-490. doi: 10.1139/bcb-2016-0198. Epub 2017 Apr 4.

PMID:
28376311
15.

Serum creatinine elevation after switch to dolutegravir in a human immunodeficiency virus-positive kidney transplant recipient.

Lee DH, Malat GE, Bias TE, Harhay MN, Ranganna K, Doyle AM.

Transpl Infect Dis. 2016 Aug;18(4):625-7. doi: 10.1111/tid.12545. Epub 2016 Jun 20.

16.

Computer-aided design of negative allosteric modulators of metabotropic glutamate receptor 5 (mGluR5): Comparative molecular field analysis of aryl ether derivatives.

Selvam C, Thilagavathi R, Narasimhan B, Kumar P, Jordan BC, Ranganna K.

Bioorg Med Chem Lett. 2016 Feb 15;26(4):1140-4. doi: 10.1016/j.bmcl.2016.01.051. Epub 2016 Jan 19.

17.

Involvement of the Antioxidant Effect and Anti-inflammatory Response in Butyrate-Inhibited Vascular Smooth Muscle Cell Proliferation.

Mathew OP, Ranganna K, Milton SG.

Pharmaceuticals (Basel). 2014 Nov 10;7(11):1008-27. doi: 10.3390/ph7111008.

18.

Successful treatment of acute severe graft-versus-host-disease in a pancreas-after-kidney transplant recipient: case report.

Guy S, Potluri A, Xiao G, Vega ML, Malat G, Ranganna K, Cusack C, Doyle AM.

Transplant Proc. 2014 Sep;46(7):2446-9. doi: 10.1016/j.transproceed.2014.06.049. Epub 2014 Aug 30.

PMID:
25179161
19.

Validation of the Maryland Aggregate Pathology Index (MAPI), a pre-implantation scoring system that predicts graft outcome.

Philosophe B, Malat GE, Soundararajan S, Barth RN, Manitpisikul W, Wilson NS, Ranganna K, Drachenberg CB, Papadimitriou JC, Neuman BP, Munivenkatappa RB.

Clin Transplant. 2014 Aug;28(8):897-905. doi: 10.1111/ctr.12400. Epub 2014 Jul 8.

PMID:
24931144
20.

Kidney donor risk index (KDRI) fails to predict kidney allograft survival in HIV (+) recipients.

Malat G, Jindal RM, Mehta K, Gracely E, Ranganna K, Doyle A.

Transplantation. 2014 Aug 27;98(4):436-42. doi: 10.1097/TP.0000000000000073.

PMID:
24621536
21.

High frequency of rejections in HIV-positive recipients of kidney transplantation: a single center prospective trial.

Malat GE, Ranganna KM, Sikalas N, Liu L, Jindal RM, Doyle A.

Transplantation. 2012 Nov 27;94(10):1020-4. doi: 10.1097/TP.0b013e31826c3947.

PMID:
23169224
22.

Bone disease in organ transplant patients: pathogenesis and management.

Chauhan V, Ranganna KM, Chauhan N, Vaid M, Kelepouris E.

Postgrad Med. 2012 May;124(3):80-90. doi: 10.3810/pgm.2012.05.2551. Review.

PMID:
22691902
23.

Differential cellular and molecular effects of butyrate and trichostatin a on vascular smooth muscle cells.

Milton SG, Mathew OP, Yatsu FM, Ranganna K.

Pharmaceuticals (Basel). 2012 Sep 4;5(9):925-43. doi: 10.3390/ph5090925.

25.

Effect of peroxisome proliferator-activated receptor-alpha siRNA on hypertension and renal injury in the rat following nitric oxide withdrawal and high salt diet.

Newaz M, Ranganna K, Truong LD, Oyekan A.

J Hypertens. 2009 Nov;27(11):2223-31. doi: 10.1097/HJH.0b013e328330b6d9.

PMID:
19834340
26.

African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors.

Malat GE, Culkin C, Palya A, Ranganna K, Kumar MS.

Drugs. 2009 Oct 22;69(15):2045-62. doi: 10.2165/11318570-000000000-00000.

PMID:
19791826
27.

Renal failure in patients with cirrhosis.

Mackelaite L, Alsauskas ZC, Ranganna K.

Med Clin North Am. 2009 Jul;93(4):855-69, viii. doi: 10.1016/j.mcna.2009.03.003. Review.

PMID:
19577118
28.

Hormone therapy and loss of kidney function.

Palya AV, Cuhaci B, Ranganna KM.

Kidney Int. 2009 Feb;75(4):442. doi: 10.1038/ki.2008.588. No abstract available.

29.

Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.

Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4.

PMID:
18773960
30.

Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy.

Anil Kumar MS, Khan S, Ranganna K, Malat G, Sustento-Reodica N, Meyers WC.

Am J Transplant. 2008 Mar;8(3):574-85. doi: 10.1111/j.1600-6143.2007.02099.x.

31.

Involvement of glutathione/glutathione S-transferase antioxidant system in butyrate-inhibited vascular smooth muscle cell proliferation.

Ranganna K, Mathew OP, Yatsu FM, Yousefipour Z, Hayes BE, Milton SG.

FEBS J. 2007 Nov;274(22):5962-78. Epub 2007 Oct 24.

32.

Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease.

Verma A, Ranganna KM, Reddy RS, Verma M, Gordon NF.

Am J Cardiol. 2005 Nov 1;96(9):1290-2. Epub 2005 Sep 8.

PMID:
16253600
33.

Mechanism of acrolein-induced vascular toxicity.

Yousefipour Z, Ranganna K, Newaz MA, Milton SG.

J Physiol Pharmacol. 2005 Sep;56(3):337-53.

34.
35.

Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation.

Ranganna K, Yousefipour Z, Yatsu FM, Milton SG, Hayes BE.

Mol Cell Biochem. 2003 Dec;254(1-2):21-36.

PMID:
14674679
36.

Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation.

Kode R, Fa K, Chowdhury S, Ranganna K, Fyfe B, Stabler S, Damask A, Laftavi MR, Kumar AM, Pankewycz O.

Clin Transplant. 2003 Aug;17(4):369-76.

PMID:
12868995
37.

Acrolein activates mitogen-activated protein kinase signal transduction pathways in rat vascular smooth muscle cells.

Ranganna K, Yousefipour Z, Nasif R, Yatsu FM, Milton SG, Hayes BE.

Mol Cell Biochem. 2002 Nov;240(1-2):83-98.

PMID:
12487375
38.

Oliguria: fluid deprivation or furosemide deficiency?

Cuhaci B, Ranganna KM.

Crit Care Med. 2002 Jun;30(6):1402. No abstract available.

PMID:
12072712
39.

Diagnosis of unexplained bleeding from tunneled dialysis catheter.

Huang EY, Cohen S, Lee J, Ranganna K, Quinn TJ, Weiss J, Ahmed Z.

Am J Nephrol. 2001 Sep-Oct;21(5):397-9.

PMID:
11684802
40.

Induction strategy using basiliximab combined with mycophenolate MMF and immediate low-dose cyclosporin is steroid sparing and more effective than OKT3.

Chowdhury S, Kode RK, Ranganna K, Damask AM, Lam A, Fyfe B, Stabler S, Kumar AM, Tomeny MB, Kumar MS, Pankewycz O.

Transplant Proc. 2001 Feb-Mar;33(1-2):1057-8. No abstract available.

PMID:
11267189
41.

Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cells.

Ranganna K, Yatsu FM, Hayes BE, Milton SG, Jayakumar A.

Mol Cell Biochem. 2000 Feb;205(1-2):149-61.

PMID:
10821433
43.

Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells.

Ranganna K, Joshi T, Yatsu FM.

Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2273-83.

PMID:
7489253

Supplemental Content

Loading ...
Support Center